Cite Filings / ENTA / 0001193125-26-046712
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
S-3

Registration Statement

ENANTA PHARMACEUTICALS INC · Filed 2026-02-11 · Acc 0001193125-26-046712

Documents 1

  • S-3 Registration Statement , d107341ds3.htm

Around this filing

  • 2026-02-13 4 Chief Product Strategy Officer gave up 3,257 shares (to pay taxes)
  • 2026-02-13 4 Chief Scientific Officer gave up 3,413 shares (to pay taxes)
  • 2026-02-13 4 President and CEO gave up 6,155 shares (to pay taxes)
  • 2026-02-11 S-3 Registration Statement
  • 2026-02-11 10-Q Quarterly Report
  • 2026-02-09 8-K Results of operations
  • 2023-11-22 S-3 Registration Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d107341ds3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…